Literature DB >> 3161206

Determination of plasma protein S--the protein cofactor of activated protein C.

R M Bertina, A van Wijngaarden, J Reinalda-Poot, S R Poort, V J Bom.   

Abstract

Protein S, an important cofactor of activated protein C, and C4b-binding protein were purified from human plasma. Specific antibodies against the purified proteins were raised in rabbits and used for the development of immunologic assays for these proteins in plasma: an immunoradiometric assay for protein S (which measures both free protein S and protein S complexed with C4b-binding protein) and an electroimmunoassay for C4b-binding protein. Ranges for the concentrations of these proteins were established in healthy volunteers and patients using oral anticoagulant therapy. A slight decrease in protein S antigen was observed in patients with liver disease (0.78 +/- 0.25 U/ml); no significant decrease in protein S was observed in patients with DIC (0.95 +/- 0.25 U/ml). Criteria were developed for the laboratory diagnosis of an isolated protein S deficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161206

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

Review 1.  Guidelines on the investigation and management of thrombophilia. The British Committee for Standards in Haematology.

Authors: 
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

2.  Necrosis of skin induced by coumarin in a patient deficient in protein S.

Authors:  V Grimaudo; F Gueissaz; J Hauert; A Sarraj; E K Kruithof; F Bachmann
Journal:  BMJ       Date:  1989-01-28

Review 3.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

Review 4.  Thrombophilia and the surgeon.

Authors:  E G Rhodes
Journal:  Ann R Coll Surg Engl       Date:  1996-07       Impact factor: 1.891

5.  Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain.

Authors:  M Van Wijnen; J G Stam; G T Chang; J C Meijers; P H Reitsma; R M Bertina; B N Bouma
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

6.  Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families.

Authors:  Jorge Esparza-Gordillo; José Manuel Soria; Alfonso Buil; Joan Carles Souto; Laura Almasy; John Blangero; Jordi Fontcuberta; Santiago Rodríguez de Córdoba
Journal:  Immunogenetics       Date:  2003-02-22       Impact factor: 2.846

Review 7.  New biological concepts on coagulation inhibitors.

Authors:  N Sala; J Fontcuberta; M L Rutllant
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.

Authors:  E M Conway; K A Bauer; S Barzegar; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

9.  [The clinical importance of protein C and S deficiency for surgical patients].

Authors:  H Rabl; H Fruhwirth
Journal:  Langenbecks Arch Chir       Date:  1992

10.  Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation.

Authors:  A D'Angelo; S Vigano-D'Angelo; C T Esmon; P C Comp
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.